Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

NCT07734870

CollaboratorPhase 2Recruiting202620 people29 Jul 2026clinicaltrials.gov

NCT07580339

Phase 2Not yet recruiting202630 people12 May 2026clinicaltrials.gov

NCT07209189

Phase 2Recruiting202675 people6 Oct 2025clinicaltrials.gov

NCT07142551

Phase 2Recruiting202660 people26 Aug 2025clinicaltrials.gov

NCT06922318

Phase 2Recruiting202550 people10 Apr 2025clinicaltrials.gov

NCT06616597

Phase 2Recruiting202558 people27 Sept 2024clinicaltrials.gov

NCT06245889

Phase 2Recruiting202430 people7 Feb 2024clinicaltrials.gov

NCT06059118

Phase 2Recruiting202350 people28 Sept 2023clinicaltrials.gov

NCT06001658

Phase 2Recruiting202427 people21 Aug 2023clinicaltrials.gov

NCT05501548

Phase 2Terminated20234 people15 Aug 2022clinicaltrials.gov

NCT05312671

Phase 2Recruiting202263 people5 Apr 2022clinicaltrials.gov

NCT05081193

Phase 2Active, not recruiting202215 people18 Oct 2021clinicaltrials.gov

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

Phase 1Active, not recruiting202231 people19 Aug 2021clinicaltrials.gov

NCT04753879

Phase 2Active, not recruiting202138 people15 Feb 2021clinicaltrials.gov

NCT04363164

Phase 2Recruiting2020150 people27 Apr 2020clinicaltrials.gov

NCT03554317

Phase 2Completed201845 people13 Jun 2018clinicaltrials.gov

NCT03535727

Phase 1/2Completed201848 people24 May 2018clinicaltrials.gov

NCT03114865

Phase 1/2Active, not recruiting201744 people14 Apr 2017clinicaltrials.gov

NCT02995330

Phase 1Terminated20173 people16 Dec 2016clinicaltrials.gov

NCT02516670

Phase 2Terminated201650 people6 Aug 2015clinicaltrials.gov